Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models

被引:247
作者
Menalled, Liliana [1 ]
El-Khodor, Bassem F. [1 ]
Patry, Monica [1 ]
Suarez-Farinas, Mayte [2 ]
orenstein, Samantha J. [1 ]
Zahasky, Benjamin [1 ]
Leahy, Christina [1 ]
Wheeler, Vanessa [3 ]
Yang, X. William [4 ,5 ,6 ]
MacDonald, Marcy [3 ]
Morton, A. Jennifer [7 ]
Bates, Gill [8 ]
Leeds, Janet [9 ]
Park, Larry [9 ]
Howland, David [9 ]
Signer, Ethan [9 ]
Tobin, Allan [9 ]
Brunner, Daniela [1 ,10 ]
机构
[1] PsychoGenics Inc, Tarrytown, NY 10591 USA
[2] Rockefeller Univ Hosp, New York, NY 10065 USA
[3] Massachusetts Gen Hosp, Mol Neurogenet Lab, Charlestown, MA 02129 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA
[7] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England
[8] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England
[9] CHDI Fdn, New York, NY 10001 USA
[10] Columbia Univ, Dept Psychiat, New York, NY 10032 USA
关键词
ENVIRONMENTAL ENRICHMENT; MUTANT HUNTINGTIN; CAG REPEAT; TRINUCLEOTIDE REPEAT; PREPULSE INHIBITION; STARTLE RESPONSE; MOTOR DEFICITS; MICE; ABNORMALITIES; HD;
D O I
10.1016/j.nbd.2009.05.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is one of the few neurodegenerative diseases with a known genetic cause, knowledge that has enabled the creation of animal models using genetic manipulations that aim to recapitulate HD pathology. The study of behavioral and neuropathological phenotypes of these HD models, however, has been plagued by inconsistent results across laboratories stemming from the lack of standardized husbandry and testing conditions, in addition to the intrinsic differences between the models. We have compared different HD models using standardized conditions to identify the most robust phenotypic differences, best suited for preclinical therapeutic efficacy studies. With a battery of tests of sensory-motor function, such as the open field and prepulse inhibition tests, we replicate previous results showing a strong and progressive behavioral deficit in the R6/2 line with an average of 129 CAG repeats in a mixed CBA/J and C57BL/6J background. We present the first behavioral characterization of a new model, an R6/2 line with an average of 248 CAG repeats in a pure C57BL/6J background, which also showed a progressive and robust phenotype. The BACHD in a FVB/N background showed robust and progressive behavioral phenotype, while the YAC128 full-length model on either an FVB/N or a C57BL/6J background generally showed milder deficits. Finally, the Hdh(Q111) knock-in mouse on a CD1 background showed very mild deficits. This first extensive standardized cross-characterization of several HD animal models under standardized conditions highlights several behavioral outcomes, such as hypoactivity, amenable to standardized preclinical therapeutic drug screening. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:319 / 336
页数:18
相关论文
共 45 条
[1]  
Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75
[2]   RETINAL DEGENERATION IN THE RD MOUSE IS CAUSED BY A DEFECT IN THE BETA-SUBUNIT OF ROD CGMP-PHOSPHODIESTERASE [J].
BOWES, C ;
LI, TS ;
DANCIGER, M ;
BAXTER, LC ;
APPLEBURY, ML ;
FARBER, DB .
NATURE, 1990, 347 (6294) :677-680
[3]  
Carter RJ, 1999, J NEUROSCI, V19, P3248
[4]   CAG repeat lengths ≥335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse [J].
Dragatsis, I. ;
Goldowitz, D. ;
Del Mar, N. ;
Deng, Y. P. ;
Meade, C. A. ;
Liu, Li ;
Sun, Z. ;
Dietrich, P. ;
Yue, J. ;
Reiner, A. .
NEUROBIOLOGY OF DISEASE, 2009, 33 (03) :315-330
[5]   Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? [J].
Gerlai, R .
TRENDS IN NEUROSCIENCES, 1996, 19 (05) :177-181
[6]   Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors [J].
Glass, M ;
Van Dellen, A ;
Blakemore, C ;
Hannan, AJ ;
Faull, RLM .
NEUROSCIENCE, 2004, 123 (01) :207-212
[7]   Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice [J].
Gray, Michelle ;
Shirasaki, Dyna I. ;
Cepeda, Carlos ;
Andre, Veronique M. ;
Wilburn, Brian ;
Lu, Xiao-Hong ;
Tao, Jifang ;
Yamazaki, Irene ;
Li, Shi-Hua ;
Sun, Yi E. ;
Li, Xiao-Jiang ;
Levine, Michael S. ;
Yang, X. William .
JOURNAL OF NEUROSCIENCE, 2008, 28 (24) :6182-6195
[8]   A POLYMORPHIC DNA MARKER GENETICALLY LINKED TO HUNTINGTONS-DISEASE [J].
GUSELLA, JF ;
WEXLER, NS ;
CONNEALLY, PM ;
NAYLOR, SL ;
ANDERSON, MA ;
TANZI, RE ;
WATKINS, PC ;
OTTINA, K ;
WALLACE, MR ;
SAKAGUCHI, AY ;
YOUNG, AB ;
SHOULSON, I ;
BONILLA, E ;
MARTIN, JB .
NATURE, 1983, 306 (5940) :234-238
[9]   Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing [J].
Hickey, MA ;
Gallant, K ;
Gross, GG ;
Levine, MS ;
Chesselet, MF .
NEUROBIOLOGY OF DISEASE, 2005, 20 (01) :1-11
[10]   Standardization and statistical approaches to therapeutic trials in the R6/2 mouse [J].
Hockly, E ;
Woodman, B ;
Mahal, A ;
Lewis, CM ;
Bates, G .
BRAIN RESEARCH BULLETIN, 2003, 61 (05) :469-479